In this episode, we sat down with Jamil Beg, Partner at 5AM Ventures, a leading venture capital firm focused on building next-generation life science companies. We discuss Jamil's career journey, the challenges in scaling early-stage biotech companies, the current life science investing landscape, and much more.Founded in 2002, 5AM has invested in 100 companies and raised over $2.0 billion since inception. Through its 

Initiative, 5AM discovers, incubates, and funds breakthrough science by partnering with academics and entrepreneurs to establish proof-of-concept data that will enable a Series A financing. 5AM has offices in Boston and San Francisco.

Molly Gibson, Co-Founder of Generate Biomedicines, on Innovating at the Intersection of AI/ML and Biotech

LifeSci Beat is a Wharton MBA student-run podcast dedicated to exploring the business of innovation in the life sciences. We are focused on chronicling the latest discoveries in life sciences (biotech, medtech, diagnostics, and more) and uncovering the business challenges faced by leaders in bringing cutting edge technology to market.